Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Samsung BioLogics
Pharma
Summit, UCB-Candid, J&J—Fierce Pharma Asia
Summit's PD-1xVEGF trial missed an interim analysis. UCB will buy Candid for $2 billion. J&J cut two CAR-T programs from its AbelZeta deal.
Angus Liu
May 8, 2026 8:30am
Thousands-wide union strike continues at CDMO Samsung Biologics
May 4, 2026 11:30am
Samsung Biologics' labor union holds general strike
May 1, 2026 11:00am
Merck, Zai Lab, Kailera-Hengrui—Fierce Pharma Asia
Apr 24, 2026 8:22am
Union strike looms at Samsung Bio amid massive revenue growth
Apr 22, 2026 11:28am
Drug tariffs, Takeda, Lilly-Insilico—Fierce Pharma Asia
Apr 3, 2026 7:49am
